Target intelligence / Profile preview

E protein-DNA cis-regulatory complex (E-protein/DNA complex)

Target
E-protein/DNA complex
Molecular classification
Transcription factor, Protein-DNA complex, Basic helix-loop-helix (bHLH) family
01

Overview

E protein-DNA cis-regulatory complexes are fundamental transcriptional assemblies composed of Class I basic helix-loop-helix (bHLH) transcription factors—primarily E2A (TCF3), E2-2 (TCF4), and HEB (TCF12)—bound to specific DNA sequences known as E-boxes (CANNTG). These complexes play a critical role in orchestrating the development of the immune system, particularly the specification and commitment of B and T cell lineages by activating lineage-specific enhancers (Murre, 2012, PMID: 22306292). In a healthy state, their activity is tightly regulated by Inhibitor of DNA binding (Id) proteins, which sequester E proteins to prevent DNA binding. Dysregulation of these complexes, through genetic translocations, mutations, or altered expression of Id proteins, is a hallmark of various lymphoid malignancies, including acute lymphoblastic leukemia and Burkitt lymphoma (Kee, 2009, PMID: 19144325). Consequently, these complexes are emerging as therapeutic targets, with research focusing on small molecules or biological agents that can modulate E protein dimerization or their recruitment to cis-regulatory elements to restore normal gene expression patterns.

Other names
E-box binding complexClass I bHLH-DNA complexTCF3-DNA complexTCF4-DNA complexTCF12-DNA complex
02

Mechanism of action

Competitive inhibition of DNA binding and disruption of bHLH dimerization

03

Biological functions

Gene expression regulationLymphopoiesisB-cell developmentT-cell developmentCell fate specificationEnhancer activation
04

Disease associations

Acute lymphoblastic leukemiaBurkitt lymphomaAgammaglobulinemiaT-cell lymphomaImmunodeficiency
05

Safety considerations

Hematopoietic toxicityImpaired adaptive immune responseOff-target transcriptional changes in non-lymphoid tissues
06

Interacting drugs

Experimental bHLH inhibitors

2 more in the full profile.

07

Biomarkers

E-box motif occupancyTCF3 (E2A) expression levelsRAG1/RAG2 expressionTCF3-PBX1 fusion transcriptId1/Id2/Id3 expression levels

Beyond the preview

Go deeper on E protein-DNA cis-regulatory complex (E-protein/DNA complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E protein-DNA cis-regulatory complex (E-protein/DNA complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call